Quantbot Technologies LP Purchases Shares of 66,443 Haleon plc (NYSE:HLN)

Quantbot Technologies LP acquired a new stake in Haleon plc (NYSE:HLN) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 66,443 shares of the company’s stock, valued at approximately $634,000.

Several other institutional investors also recently modified their holdings of the company. Thrivent Financial for Lutherans raised its stake in Haleon by 69.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 55,593 shares of the company’s stock valued at $588,000 after acquiring an additional 22,701 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Haleon by 41.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 203,583 shares of the company’s stock valued at $2,154,000 after purchasing an additional 59,719 shares during the period. Cerity Partners LLC lifted its stake in shares of Haleon by 23.4% during the 3rd quarter. Cerity Partners LLC now owns 576,533 shares of the company’s stock worth $6,100,000 after buying an additional 109,311 shares during the last quarter. Brown Brothers Harriman & Co. boosted its holdings in shares of Haleon by 80.4% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 13,653 shares of the company’s stock worth $144,000 after buying an additional 6,084 shares during the period. Finally, FMR LLC grew its stake in Haleon by 5.8% in the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after buying an additional 5,768,117 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Hsbc Global Res downgraded shares of Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Finally, HSBC reissued a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $10.95.

Haleon Trading Up 0.7 %

Shares of HLN stock opened at $10.12 on Friday. The stock has a market cap of $45.81 billion, a P/E ratio of 29.76, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. Haleon plc has a 1 year low of $7.99 and a 1 year high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a 50 day simple moving average of $9.92 and a 200 day simple moving average of $9.88.

Haleon (NYSE:HLN) last released its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The firm had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. On average, research analysts predict that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The company also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.1166 per share. This represents a yield of 1.6%. This is an increase from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio is presently 58.97%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.